This WHO Medical Product Alert refers to one batch of falsified Combiart (combination of artemether and lumefantrine) that was identified in Chad, Côte d’Ivoire, and Mali and reported to WHO in November 2021.

The falsified product was reported at the patient level outside authorized and regulated supply chains of the above-mentioned countries.
Genuine Combiart is indicated for the treatment of acute malaria and while analyses of the product that were conducted found that the two expected active ingredients(artemether and lumefantrine) were not detected.

To read more:

This may interest you